Annual Gross Margin
N/A
31 December 2022
Summary:
Nymox Pharmaceutical annual gross profit margin is not available.NYMX Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
N/A
31 March 2023
Summary:
Nymox Pharmaceutical quarterly gross profit margin is not available.NYMX Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Gross Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
NYMX Gross Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time |
Nymox Pharmaceutical Gross Margin History
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | 20.00%(-60.0%) | - |
Mar 2020 | - | 20.00%(-72.6%) |
Dec 2019 | 50.00%(-7.1%) | 73.08%(+23.9%) |
Sept 2019 | - | 58.97%(-9.3%) |
June 2019 | - | 65.00%(+1852.0%) |
Mar 2019 | - | 3.33%(-106.3%) |
Dec 2018 | 53.85%(+60.8%) | -52.63%(-240.3%) |
Sept 2018 | - | 37.50%(-48.4%) |
June 2018 | - | 72.73%(+18.9%) |
Mar 2018 | - | 61.18%(+7.1%) |
Dec 2017 | 33.48%(-14.3%) | 57.14%(-985.9%) |
Sept 2017 | - | -6.45%(-96.8%) |
June 2017 | - | -200.00%(-572.7%) |
Mar 2017 | - | 42.31%(+243.1%) |
Dec 2016 | 39.08%(-58.5%) | 12.33%(-5.9%) |
Sept 2016 | - | 13.10%(-81.9%) |
June 2016 | - | 72.38%(-425.4%) |
Mar 2016 | - | -22.24%(-194.0%) |
Dec 2015 | 94.21%(+0.1%) | 23.67%(-31.2%) |
Sept 2015 | - | 34.39%(-11.1%) |
June 2015 | - | 38.70%(-60.7%) |
Mar 2015 | - | 98.55%(+1.8%) |
Dec 2014 | 94.11%(+10.0%) | 96.84%(+3.2%) |
Sept 2014 | - | 93.83%(+0.3%) |
June 2014 | - | 93.59%(+1.5%) |
Mar 2014 | - | 92.21%(+21.6%) |
Dec 2013 | 85.53%(-6.8%) | 75.84%(-18.9%) |
Sept 2013 | - | 93.51%(+12.9%) |
June 2013 | - | 82.80%(-10.0%) |
Mar 2013 | - | 92.01%(-1.4%) |
Dec 2012 | 91.74%(+1.2%) | 93.36%(+1.2%) |
Sept 2012 | - | 92.26%(+2.8%) |
June 2012 | - | 89.76%(-1.9%) |
Mar 2012 | - | 91.53%(-0.2%) |
Dec 2011 | 90.69%(+67.4%) | 91.68%(+5.6%) |
Sept 2011 | - | 86.85%(-9.5%) |
June 2011 | - | 95.92%(+8.4%) |
Mar 2011 | - | 88.49%(+16.3%) |
Dec 2010 | 54.16% | 76.12%(-225.8%) |
Sept 2010 | - | -60.52%(-576.9%) |
June 2010 | - | 12.69%(-77.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | 56.37%(+27.2%) |
Dec 2009 | 40.84%(+5.3%) | 44.31%(-28.7%) |
Sept 2009 | - | 62.11%(+57.5%) |
June 2009 | - | 39.44%(+96.5%) |
Mar 2009 | - | 20.07%(-64.4%) |
Dec 2008 | 38.77%(-12.6%) | 56.30%(+1250.1%) |
Sept 2008 | - | 4.17%(-91.2%) |
June 2008 | - | 47.49%(+32.4%) |
Mar 2008 | - | 35.87%(-31.1%) |
Dec 2007 | 44.36%(-2.5%) | 52.03%(+112.4%) |
Sept 2007 | - | 24.50%(-48.3%) |
June 2007 | - | 47.35%(+5.4%) |
Mar 2007 | - | 44.94%(+18.4%) |
Dec 2006 | 45.49%(-11.4%) | 37.97%(-20.4%) |
Sept 2006 | - | 47.68%(-30.6%) |
June 2006 | - | 68.72%(+248.1%) |
Mar 2006 | - | 19.74%(-48.6%) |
Dec 2005 | 51.36%(+21.2%) | 38.43%(-34.0%) |
Sept 2005 | - | 58.21%(+7.5%) |
June 2005 | - | 54.14%(-1.5%) |
Mar 2005 | - | 54.97%(-23.9%) |
Dec 2004 | 42.36%(+10.6%) | 72.20%(+175.0%) |
Sept 2004 | - | 26.25%(-35.4%) |
June 2004 | - | 40.64%(+23.8%) |
Mar 2004 | - | 32.82%(-14.2%) |
Dec 2003 | 38.31%(-4.5%) | 38.27%(+13.0%) |
Sept 2003 | - | 33.87%(-23.9%) |
June 2003 | - | 44.50%(+38.2%) |
Mar 2003 | - | 32.19%(-352.7%) |
Dec 2002 | 40.11%(-8.7%) | -12.74%(-129.0%) |
Sept 2002 | - | 43.91%(+3.2%) |
June 2002 | - | 42.53%(-37.9%) |
Mar 2002 | - | 68.54%(-42.4%) |
Dec 2001 | 43.94%(-1.3%) | 119.08%(+44.8%) |
Sept 2001 | - | 82.21%(+11.1%) |
June 2001 | - | 73.97%(+12.6%) |
Mar 2001 | - | 65.68%(+43.4%) |
Dec 2000 | 44.54%(+36.8%) | - |
Mar 2000 | - | 45.79% |
Dec 1999 | 32.57%(-56.1%) | - |
Dec 1998 | 74.17% | - |
FAQ
- What is the all time high annual gross margin for Nymox Pharmaceutical?
- What is the all time high quarterly gross margin for Nymox Pharmaceutical?
What is the all time high annual gross margin for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual gross profit margin is 94.21%
What is the all time high quarterly gross margin for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly gross profit margin is 119.08%